Basic Information
RNALocate ID: | RLID:01002018 |
RNA Symbol: | hsa-miR-362-5p |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-362-5p |
RNA ID: | miRBase:MIMAT0000705 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21637849 |
Tissue/Cell Line: | Skeletal muscle myoblasts |
Method: | ISH|qRT-PCR |
Description: | List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002017 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002019 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002020 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11002427 | Exosome | Serum | 18589210 |
RLID:11002428 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002429 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11002430 | Exosome | Brain tissue | 23382797 |
RLID:11002431 | Exosome | Plasma | 23663360 |
RLID:11002432 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11002433 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000407 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001191 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-362-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-43780 |
MNDR | hsa-miR-362-5p | Oral squamous cell carcinoma | MNDR-E-MI-43781 |
MNDR | hsa-miR-362-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-43782 |
MNDR | hsa-miR-362-5p | Ovarian clear cell carcinoma | MNDR-E-MI-43783 |
MNDR | hsa-miR-362-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-43784 |
MNDR | hsa-miR-362-5p | Lymphoma | MNDR-E-MI-43785 |
MNDR | hsa-miR-362-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-43786 |
MNDR | hsa-miR-362-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-43787 |
MNDR | hsa-miR-362-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-43788 |
MNDR | hsa-miR-362-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-43789 |
MNDR | hsa-miR-362-5p | Her2-receptor positive breast cancer | MNDR-E-MI-43790 |
MNDR | hsa-miR-362-5p | Breast cancer luminal | MNDR-E-MI-43791 |
MNDR | hsa-miR-362-5p | Neurofibromatosis 1 | MNDR-E-MI-43792 |
MNDR | hsa-miR-362-5p | Dermatomyositis | MNDR-E-MI-43793 |
MNDR | hsa-miR-362-5p | Prostate cancer | MNDR-E-MI-43794 |
MNDR | hsa-miR-362-5p | Chronic lymphocytic leukemia | MNDR-E-MI-43795 |
MNDR | hsa-miR-362-5p | Gastric cancer | MNDR-E-MI-43796 |
MNDR | hsa-miR-362-5p | Alzheimer disease | MNDR-E-MI-43797 |
MNDR | hsa-miR-362-5p | Intracranial aneurysm | MNDR-E-MI-43798 |
MNDR | hsa-miR-362-5p | Esophageal carcinoma | MNDR-E-MI-43799 |
MNDR | hsa-miR-362-5p | Dysautonomia familial | MNDR-E-MI-43800 |
MNDR | hsa-miR-362-5p | Leukemia | MNDR-E-MI-43801 |
MNDR | hsa-miR-362-5p | Down syndrome | MNDR-E-MI-43802 |
MNDR | hsa-miR-362-5p | Parkinson disease | MNDR-E-MI-43803 |
MNDR | hsa-miR-362-5p | Basal-like breast cancer | MNDR-E-MI-43804 |
MNDR | hsa-miR-362-5p | Pancreatic cancer | MNDR-E-MI-43805 |
MNDR | hsa-miR-362-5p | Melanoma | MNDR-E-MI-43806 |
MNDR | hsa-miR-362-5p | Rectum adenocarcinoma | MNDR-E-MI-43807 |
MNDR | hsa-miR-362-5p | Nephroblastoma | MNDR-E-MI-43808 |
MNDR | hsa-miR-362-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-43809 |
MNDR | hsa-miR-362-5p | Ovarian cancer | MNDR-E-MI-43810 |
MNDR | hsa-miR-362-5p | Prostate adenocarcinoma | MNDR-E-MI-43811 |
MNDR | hsa-miR-362-5p | Invasive ductal carcinoma | MNDR-E-MI-43812 |
MNDR | hsa-miR-362-5p | Glioblastoma | MNDR-E-MI-43813 |
MNDR | hsa-miR-362-5p | Glioma | MNDR-E-MI-43814 |
MNDR | hsa-miR-362-5p | Nemaline myopathy | MNDR-E-MI-43815 |
MNDR | hsa-miR-362-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-43816 |
MNDR | hsa-miR-362-5p | Gastric adenocarcinoma | MNDR-E-MI-43817 |
MNDR | hsa-miR-362-5p | Cervical squamous cell carcinoma | MNDR-E-MI-43818 |
MNDR | hsa-miR-362-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-43819 |
MNDR | hsa-miR-362-5p | Lung squamous cell carcinoma | MNDR-E-MI-43820 |
MNDR | hsa-miR-362-5p | Lung adenocarcinoma | MNDR-E-MI-43821 |
MNDR | hsa-miR-362-5p | Adrenocortical cancer | MNDR-E-MI-43822 |
MNDR | hsa-miR-362-5p | Thyroid carcinoma | MNDR-E-MI-43823 |
MNDR | hsa-miR-362-5p | Ovarian carcinoma | MNDR-E-MI-43824 |
MNDR | hsa-miR-362-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-43825 |
MNDR | hsa-miR-362-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-43826 |
MNDR | hsa-miR-362-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-43827 |
MNDR | hsa-miR-362-5p | Clear cell renal cell carcinoma | MNDR-E-MI-43828 |
MNDR | hsa-miR-362-5p | Cholangiocarcinoma | MNDR-E-MI-43829 |
MNDR | hsa-miR-362-5p | Oncocytoma | MNDR-E-MI-43830 |
MNDR | hsa-miR-362-5p | Lung small cell carcinoma | MNDR-E-MI-43831 |
MNDR | hsa-miR-362-5p | Stomach carcinoma | MNDR-E-MI-43832 |
MNDR | hsa-miR-362-5p | Hepatocellular carcinoma | MNDR-E-MI-43833 |
MNDR | hsa-miR-362-5p | Neuroblastoma | MNDR-E-MI-43834 |
MNDR | hsa-miR-362-5p | Hodgkin lymphoma | MNDR-E-MI-43835 |
MNDR | hsa-miR-362-5p | Tonsil cancer | MNDR-E-MI-43836 |
MNDR | hsa-miR-362-5p | Colorectal cancer | MNDR-E-MI-43837 |
MNDR | hsa-miR-362-5p | Multiple myeloma | MNDR-E-MI-43838 |
MNDR | hsa-miR-362-5p | Polymyositis | MNDR-E-MI-43839 |
MNDR | hsa-miR-362-5p | Stroke lacunar | MNDR-E-MI-43840 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CYLD | Homo sapiens | RR00385272 |
TOP